Increasing use of technology and broader adoption of decentralized clinical trials (DCTs) will require an unprecedented transformation of the clinical research workforce.
This white paper highlights recent trends in technology use in clinical trials; definitions of fully decentralized and “hybrid” trials; technology impacts on traditional workforce roles; and potential new roles likely to emerge.
Major conclusions include: